(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 16.54% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Clearpoint Neuro's revenue in 2026 is $42,279,000.On average, 4 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,524,601,265, with the lowest CLPT revenue forecast at $1,434,918,838, and the highest CLPT revenue forecast at $1,601,471,918. On average, 4 Wall Street analysts forecast CLPT's revenue for 2027 to be $1,759,514,318, with the lowest CLPT revenue forecast at $1,674,071,978, and the highest CLPT revenue forecast at $1,828,880,930.
In 2028, CLPT is forecast to generate $2,053,544,562 in revenue, with the lowest revenue forecast at $1,973,013,402 and the highest revenue forecast at $2,113,942,931.